Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke

Cardiovascular Ultrasound

Volumn 3, Issue , 2005, Pages

  Doepp, Florian ^a   Sanad, Wasiem ^a   Schreiber, Stephan J ^a   Baumann, Gert ^a   Borges, Adrian C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; DALTEPARIN; HEPARIN;

ADULT; APHASIA; ARTICLE; CASE REPORT; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; FIBRINOLYTIC THERAPY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE THROMBOSIS; HEMIPARESIS; HUMAN; LOW DRUG DOSE; MALE; NEUROLOGIC EXAMINATION; SYMPTOM; TACHYCARDIA; THROMBOGENESIS; THROMBOSIS; THROMBUS; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ACUTE DISEASE; BRAIN ISCHEMIA; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; MALE; MIDDLE AGED; STROKE; THROMBOLYTIC THERAPY; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 23044456712     PISSN: 14767120     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-3-14     Document Type: Article

References (22)

1. The National Institute of Neurological Diseases and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for ischaemic stroke. N Engl J Med 1995, 333:1581-1587.
2. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, for the ECASS Group: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study. JAMA 1995, 274:1017-1025.
3. Fassbender K, Dempfle CE, Mielke O, Schwartz A, Daffertshofer M, Eschenfelder C, Dollman M, Hennerici M: Changes in Coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant plasminogen activator. Stroke 1999, 30:2101-2104.
4. Paganelli F, Alessi MC, Morange P, Maixent JM, Levy S, Vague IJ: Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery. Thromb Haemost 1999, 82:104-108.
5. Frostfeldt G, Gustavsson G, Lindahl B, Nygren A, Wallentin L: Influence on coagulation activity by subcutaneous LMW heparin as an adjuvant treatment to fibrinolysis in acute myocardial infarction. Thrombosis Research 2002, 105:193-199.
6. Kuker W, Friese S, Vogel W, Schmidt F, Weller M: Incomplete resolution of basilar artery occlusion after intra-arterial thrombolysis: abciximab and heparin prevent early rethrombosis. Cerebrovasc Dis 2000, 10:484-486.
7. Wardlaw JM, Zoppo G, Yamaguchi T, Berge E: Thrombolysis for acute ischaemic stroke. Cochrane Databaes Syst Rev 2003, :CDOOO213.
8. Adams H, Adams R, Del Zoppo G, Goldstein LB: Guidelines for the Early Management of Patients With Ischemic Stroke: 2005 Guidelines Update: A Scientific Statement From the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005, 36:916-921.
9. Schenkel J, Weimar C, Knoll T, Haberl RL, Busse O, Hamann GF, Koennecke HC, Diener HC: R1-Systemic Thrombolysis in German Stroke Units. The experience from the German Stroke Data Bank. J Neurol 2003, 250:320-324.
10. Trouillas P, Nighoghossian N, Derex L, Adeleine P, Honnorat J, Neuschwander P, Riche G, Getenet JC, Li W, Froment JC, Turjman F, Malicier D, Fournier G, Gabry AL, Ledoux X, Berthezene Y, Ffrench P, Dechavanne M: Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke. Determination of etiological, topographic, and radiological outcome factors. Stroke 1998, 29:2529-2540.
11. Kilic E, Bähr M, Hermann DM: Effect of recombinant tissue plasminogen activator after intraluminal thread occlusion in mice. Role of hemodynamic alterations. Stroke 2001, 32:2641-2647.
12. Maki A, Shirato C, Ohguchi M, Aoki N, Ochiai I, Ishikawa K: Mechanism of re-thrombosis after thrombolytic therapy: angiographic findings and investigation of the coagulation system in dogs. Angiology 1998, 49:447-453.
13. Nilsen DW, Goransson L, Larsen AI, Hetland O, Kierulf P: Systemic thrombin generation and activity resistant to low molecular weight heparin administered prior to streptokinase in patients with acute myocardial infarction. Thromb Haemost 1997, 77:57-61.
14. Adams RJ, Chimowitz MI, Alpert JS, Awad IA, Cerqueria MD, Fayad P, Taubert KA: Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation 2003, 108:1278-1290.
15. Greaves SC, Zhi G, Lee RT, Solomon SD, MacFadyen J, Rapaport E, Menapace FJ, Rouleau JL, Pfeffer MA: Incidence and natural history of left ventricular thrombus following anterior wall acute myocardial infarction. Am J Cardiol 1997, 80:442-448.
16. Vaitkus PT, Barnathan ES: Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. J Am Coll Cardiol 1993, 22:1004-1009.
17. Kono , et al.: Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol 1994, 24:636-640.
18. Robert , et al.: Evidence of stunned myocardium in humans: a 2001 update. Coron Artery Dis 2001, 12:349-356.
19. Bulsara , et al.: Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg 2003, 98:524-528.
20. Jain , et al.: Management of patients with stunned myocardium associated with subarachnoid hemorrhage. Am J Neuroradiol 2004, 25:126-129.
21. Ohtsuka , et al.: Neurogenic stunned myocardium. Circulation 2000, 101:2122-2124.
22. Bernstein R, Mayer SA, Magnano A: Neurogenic stunned myocardium in Guillaine-Barre syndrome. Neurology 2000, 54:759-762.